Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
AHK-Cu increased Bcl-2 and decreased Bax
Trust & Legitimacy COA Available: A Certificate of Analysis is provided with every batch
The requirement for informed consent was waived by the IRB because all data were fully anonymized within the Asan Biomedical Research Environment (ABLE) database
Response differences are based on baseline metabolic characteristics, diet, and comorbid disease
The 2017 foundational studies confirmed that 5amino1mq reduces NAD consumption via NNMT inhibition, improves glucose clearance, and decreases fat accumulation.In subsequent years, the scope expanded: a 2021 study in obese mice validated its antiobesity effects, and 2024 research revealed improvements in muscle function in aged mice.To date, the compound remains in the preclinical research stage, with no largescale human clinical trials or FDA approval for human use
US$ 21.36
US$ 24.83
US$ 24.69
US$ 23.96
US$ 27.61
US$ 27.24
US$ 27.32
US$ 28.47
